Nebulized racemic epinephrine used in the treatment of severe asthmatic exacerbation: A case report and literature review

Canadian Journal of Emergency Medicine

Volumn 9, Issue 4, 2007, Pages 304-308

  Wiebe, Kristopher ^a,b   Rowe, Brian H ^c  

^a Chilliwack General Hospital   (Canada)

^b University of Alberta ^*  (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Asthma; Bronchodilators; Emergency department

Indexed keywords

ADRENALIN; IPRATROPIUM BROMIDE; MAGNESIUM SULFATE; METHYLPREDNISOLONE; OXYGEN; SALBUTAMOL; SODIUM CHLORIDE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; OXYGEN SATURATION; PHYSICAL EXAMINATION; PNEUMOTHORAX; RACEMIC MIXTURE; RESPIRATORY DISTRESS; THORAX RADIOGRAPHY; THORAX SURGERY; VIRAL RESPIRATORY TRACT INFECTION; VITAL SIGN;

EID: 34547742553     PISSN: 14818035     EISSN: 14818035     Source Type: Journal    
DOI: 10.1017/S1481803500015220     Document Type: Article

References (27)

1. Lemiere C, Bai T, Balter M, et al. Adult Asthma Consensus Guidelines Update 2003. Can Respir J 2004;11(Suppl A):9A-18A.
2. National Asthma Education P. Expert Panel Report II. Guidelines for the Diagnosis and Management of Asthma. Bethesda, (MD): National Institutes of Health; 1997.
3. Camargo CA Jr., Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. The Cochrane Database of Systematic Reviews 2003;4:CD001115.
4. Cates CJ, Bara A, Crilly JA, et al. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma. The Cochrane Database of Systematic Reviews 2003;2:CD000052.
5. Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: A meta-analysis of randomized clinical trials. Ann Emerg Med 1999;34:8-18.
6. Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. The Cochrane Database of Systematic Reviews 2001;1:CD002178.
7. Edmonds ML, Camargo CA Jr, Pollack CV Jr, et al. The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: a meta-analysis. Ann Emerg Med 2002;40:145-54.
8. Rowe BH, Bretzlaff JA, Bourdon C, et al. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. The Cochrane Database of Systematic Reviews 2000;1:CD001490.
9. Carter ER. Heliox for acute severe asthma. Chest 2000;117: 1212-3.
10. Putland M, Kerr D, Kelly AM. Adverse events associated with the administration of intravenous epinephrine in emergency department patients presenting with severe asthma. Ann Emerg Med 2006;47:559-63.
11. Ram FSF, Wellington SR, Rowe BH, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. The Cochrane Database of Systematic Reviews 2005;1(2):CD004360
12. Weber EJ, Silverman RA, Callaham ML, et al. A prospective multicenter study of factors associated with hospital admission among adults with acute asthma. Am J Med 2002;113:371-8.
13. Ledwith C, Shea L, Mauro R. Safety and efficacy of nebulized racemic epinephrine in conjunction with dexamethasone and mist in the outpatient treatment of croup. Ann Emerg Med 1995; 25:331-5.
14. Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acuet bronchiolitis. J Pediatr 1995;126:1004-7.
15. Prendergast M, Jones JS, Hartman D. Racemic epinephrine in the treatment of laryngotracheitis: can we identify children for outpatient therapy? Am J Emerg Med 1994;12:613-6.
16. Rowe BH, Camargo CA. Emergency department treatment of severe acute asthma. Ann Emerg Med 2006;47:564-6.
17. Shaver K, Adams C, Weiss S. Acute myocardial infarction after administration of low dose epinephrine for anaphylaxis. Can J Emerg Med 2006;8:289-94.
18. Abroug F, Nouira S, Boujdaria R, et al. A controlled trial of nebulized salbutamol and adrenaline in acute severe asthma. Intensive Care Med 1995;21:18-23.
19. Adoun M, Frat JP, Dore P, et al. Comparison of nebulized epinephrine and terbutaline in patients with acute severe asthma: a controlled trial. J Crit Care 2004;19:99-102.
20. Zeggwagh A, Abouqal R, Madani N, et al. Comparative efficiency of nebulized adrenaline and salbutamol in severe acute asthma: A randomized controlled prospective study. Ann Fr Anest Reanim 2002;21:703-9.
21. Plint AC, Osmond MH, Klassen TP. The efficacy of nebulized racemic epinephrine in children with acute asthma: a randomized, double-blind trial. Acad Emerg Med 2000;7:1097-103.
22. Coupe MO, Guly U, Brown E, et al. Nebulised adrenaline in acute severe asthma: a comparison with salbutamol. Eur J Respir Dis 1987;71:227-32.
23. Rodrigo GJ, Nannini LJ. Comparison between nebulized adrenaline and beta-2 agonists for the treatment of acute asthma: a meta-analysis of randomized trials. Am J Emerg Med 2006; 24:217-22.
24. Elatrous S, Elidrissi H, Trabelsi H, et al. Dose-effect of adrenaline nebulization in asthma: comparative study with salbutamol. Rev Pneumol Clin 1997;53:187-91.
25. Waisman Y, Klein BL, Boenning DA, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics 1992;89:302-6.
26. Nutman J, Brooks LJ, Deakins KM, et al. Racemic versus L-epinephrine aerosol in the treatment of postextubation laryngeal edema: results from a prospective, randomized, doubleblind study. Crit Care Med 1994;22:1591-4.
27. Cho SH, Oh SY, Bahn JW, et al. Association between bronchodilating response to short-acting beta-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene. Clin Exp Allergy 2005;35:1162-7.